About a quarter of the world’s population will not be able to get a vaccine for protection from Kovid-19 by 2022. A report published in BMG magazine warns. Research from the US-based John Hopkins Bloomberg School of Public Health analyzed pre-orders of the Kovid-19 vaccine. Many countries of the world announced the pre-order before regulatory approval.
What will the world be able to get by 2022 Kovid-19 vaccine?
The results showed that by 15 November 2020, many countries had secured 7 billion 48 crore doses of vaccines of 13 companies for themselves. 51 percent of them will go to high-income countries. These countries represent 14 percent of the world’s population. Due to which poor and middle income countries will be left behind in getting the vaccine. However, more than 85 percent of the world’s population lives in those countries.
If all these vaccine candidates are successful, the total estimated manufacturing capacity by the end of 2021 will be 5 billion 96 crore doses. Its different prices will be from $ 6 to $ 74 per dose. Up to 40 percent of the vaccine doses of vaccine manufacturers will be available for poor and middle income countries.
Nevertheless, it will depend on how the rich countries share the purchased vaccine and whether America and Russia become partners in the global effort. But researchers point out that if all the vaccine manufacturers managed to reach their maximum production capacity, at least one fifth of the world’s population would not have access to the vaccine by 2022.
The report describes how the rich countries have secured future supplies to the Kovid-19 vaccine, while the reach of the vaccine to the rest of the world is not certain. Therefore, governments and companies should ensure equal allocation of the Kovid-19 vaccine and take care of transparency and accountability when building the system.
Pre-order analysis of rich countries reveals shocking
In other research, experts from the US and China estimated how much of the population on the global surface would need the vaccine. Which can help guide the development of a fair and equitable allocation strategy around the world. According to estimates, 68 percent of the total population of the world (3 billion 7 crore adults) is willing to take the Kovid-19 vaccine. Therefore, balancing the demand and supply of the vaccine will be a difficult task. Researchers say that both these reports are observational and the results of their analysis may be incomplete.
Why Kangna was not called for drugs investigation: Maharashtra Congress
IND Vs AUS: Ashwin is very happy after a great performance, told himself why different from others